NCT04615637

Brief Summary

Our goal is to perform a first evaluation of the capabilities of a new generation of non-invasive magnetoencephalography sensors (OPM He4) to record brain magnetic activities. The investigator will record 1) normal subjects stimulated with visual, auditory, somesthesic and motor stimuli and 2) epileptic patient. The investigator will compare the signal to noise ratio of the normal or pathological activities between classical MEG sensors and our OPM He4 prototype.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 8, 2020

Completed
4 months until next milestone

First Posted

Study publicly available on registry

November 4, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

March 1, 2021

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2023

Completed
Last Updated

February 16, 2021

Status Verified

February 1, 2021

Enrollment Period

2.3 years

First QC Date

July 8, 2020

Last Update Submit

February 15, 2021

Conditions

Keywords

MEGOPMepilepsynormal brain activity

Outcome Measures

Primary Outcomes (1)

  • Signal to Noise Ratio of the recorded brain activities

    Volunteers: The signal to noise ratio of normal brain activity following a stimulus will be computed with respect to the pre-stimulus baseline -100ms to -10 ms. Epileptic patient: The signal to noise ratio of abnormal epileptic brain activity will be computed with respect to a 100 ms baseline not containing any abnormal activity.

    1 month

Secondary Outcomes (4)

  • Signal to Noise Ratio of pre-frontal auditory activity

    one month

  • Signal to Noise Ratio of high frequency epileptic activity

    one month.

  • Comfort of the subject during the MPO He4 recordings for epileptic patient through a short verbal questionary

    5 minutes after the end the recording session

  • Comfort of the subject during the MPO He4 recordings for volunteers through a short verbal questionary

    5 minutes after the end of each recording session

Study Arms (1)

Sensors

EXPERIMENTAL

All subjects will follow the same experimental procedure: a recording using classical MEG followed by a recording in the same condition with the OPM He4 prototype.

Device: MEG recordings

Interventions

1. Classical MEG recordings (patient at rest, normal subjects stimulated with visual, motor, somesthesic and auditory stimuli). 2. MEG recordings with our OPM He4 prototype (patient at rest, normal subjects stimulated with visual, motor, somesthesic and auditory stimuli).

Sensors

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Volunteers:
  • Age 18+
  • Right handed
  • Medical insurance
  • Strongly motivated to participate to the study
  • Signed informed consent for the study
  • No previous neurology or psychiatric pathologies
  • No major cognitive deficit and able to understand the instructions
  • Patients:
  • Age 18+
  • Right handed
  • Medical insurance
  • Strongly motivated to participate to the study
  • Signed informed consent for the study
  • No previous neurology or psychiatric pathologies (except epilepsy)
  • +2 more criteria

You may not qualify if:

  • Volunteers:
  • Age \< 18 years or \> 60
  • previous neurology or psychiatric pathologies
  • Child bearing women
  • Subject having one of the following mettalic parts :
  • (pacemaker, implentable pump, neurosimulator, chochlear implant, auditory prothesis, mettalic prothesis, intracerebral clip, implantable defibrilator, any mettalic parts in the brain or upper part of the body, ventriculoperitoneal valve)
  • Patients:
  • Age \< 18 years or \> 60
  • previous neurology or psychiatric pathologies except epilepsy
  • Child bearing women
  • Subject having one of the following mettalic parts :
  • (pacemaker, implentable pump, neurosimulator, chochlear implant, auditory prothesis, mettalic prothesis, intracerebral clip, implantable defibrilator, any mettalic parts in the brain or upper part of the body, ventriculoperitoneal valve)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospices Civils de Lyon

Bron, 69500, France

Location

MeSH Terms

Conditions

Epilepsy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Julien JUNG, MD

    Hospices Civils de Lyon

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 8, 2020

First Posted

November 4, 2020

Study Start

March 1, 2021

Primary Completion

July 1, 2023

Study Completion

July 1, 2023

Last Updated

February 16, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share

Locations